Chugai Pharmaceutical Co Ltd (OTCPK:CHGCF)
$ 43.78 -3.2505 (-6.91%) Market Cap: 73.00 Bil Enterprise Value: 73.11 Bil PE Ratio: 27.66 PB Ratio: 6.65 GF Score: 81/100

Q2 2019 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript

Jul 26, 2019 / 01:00AM GMT
Release Date Price: $21.35

Jul 26, 2019 / 01:00AM GMT
Presentation
Jul 26, 2019 / 01:00AM GMT

=====================
Corporate Participants
=====================
* Osamu Okuda
Chugai Pharmaceutical Co., Ltd. - Executive VP and Co-Head of Project, Lifecycle Management Unit & Foundation Medicine
* Tatsuro Kosaka
Chugai Pharmaceutical Co., Ltd. - President, CEO & Representative Director
* Toshiaki Itagaki
Chugai Pharmaceutical Co., Ltd. - EVP, CFO and GM of Finance Supervisory Division, Finance & Accounting Dept.
* Yasushi Ito
Chugai Pharmaceutical Co., Ltd. - Executive VP and Co-Head of Project & Lifecycle Management Unit

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot